20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Propofol Infusion Syndrome (PRIS) in Veterinary Medicine: A Rare but Serious Concern

Propofol Injection is generally considered safe and effective in veterinary practice when used appropriately. However, like any potent medication, it carries potential risks, one of the most serious being Propofol Infusion Syndrome (PRIS). While rare, PRIS is a critical condition associated with prolonged, high-dose infusions of Propofol and requires a thorough understanding by veterinary professionals.

PRIS is characterized by a constellation of metabolic disturbances and organ system dysfunction. Key features include metabolic acidosis, rhabdomyolysis (muscle breakdown), hyperlipidemia (high blood fat levels), cardiac dysfunction, and kidney failure. The exact mechanism is not fully understood but is thought to involve impaired mitochondrial fatty acid metabolism. In veterinary medicine, PRIS is more commonly observed in patients receiving continuous high-dose Propofol infusions for extended periods, often exceeding 48 hours, or at doses higher than typically recommended for routine anesthesia. Critically ill patients, especially those also receiving catecholamines or steroids, may be at increased risk.

Recognizing the early signs of PRIS is crucial for timely intervention. Symptoms can include refractory bradycardia (slow heart rate) progressing to asystole, increased anion gap metabolic acidosis, and elevations in creatine kinase or triglycerides. The immediate step upon suspicion of PRIS is to discontinue the Propofol infusion and provide supportive care. Given the potential for severe outcomes, vigilance in monitoring patients on prolonged Propofol infusions is essential. Sourcing high-quality Propofol Injection from reliable manufacturers like NINGBO INNO PHARMCHEM CO.,LTD. is fundamental, as product integrity is key. While the risk of PRIS is low with standard veterinary protocols, awareness and preparedness are vital for safeguarding animal patients undergoing intensive or prolonged sedation.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Propofol Injection: Understanding Potential Drug Interactions in Veterinary Medicine

Next: Understanding Albendazole: A Crucial Anthelmintic for Global Health

All Rights Reserved